ADXN · Categories · Form 4
ADXN - SEC Form 4 insider transactions
Addex Therapeutics Ltd (ADXN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for ADXN
- SEC Form 4 filed by PRINCIPAL ACCOUNTING OFFICER Teyssedou Lenaic Nathanael4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- HEAD OF TRANSLATIONAL SCIENCE Kalinichev Mikhail returned 306,765 shares to the company and was granted 306,765 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- Director Nunn Jason Raleigh returned 219,561 shares to the company and was granted 219,561 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- CHIEF MEDICAL OFFICER Mills Roger returned 392,837 shares to the company and was granted 392,837 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- Director Manke Isaac returned 219,561 shares to the company and was granted 219,561 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- Director Lawton Vincent Michael returned 2,507,487 shares to the company and was granted 2,507,487 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- Director Hill Raymond George returned 1,365,532 shares to the company and was granted 1,365,532 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)
- CHIEF EXECUTIVE OFFICER Dyer Timothy Mark returned 16,413,787 shares to the company and was granted 16,413,787 shares (SEC Form 4)4 - Addex Therapeutics Ltd. (0001574232) (Issuer)